Trigeminal Neuralgia is a rare, incurable neurological disease that afflicts roughly one in 25,000 people. There are palliative measures that can be taken from medicines (e.g., gabapentin, carbamazepine, and pregabalin [aka Lyrica] to name but three) to surgical procedures (glycerol rhizotomy, microvascular decompression of the trigeminal nerve at the root entry zone [REZ], and gamma knife surgery. Rarely is Trigeminal Neuralgia deemed medically "intractable"; that is, that after all attempts at palliative care have been made, the disease no longer responds to the accepted/prescribed forms of treatment by any one or a combination of palliative measures. So there is always hope for a full and meaningful life in spite of this disease.